Johnson & Johnson
JNJ
$224.26
$2.831.28%
NYSE
| 03/29/2026 | 12/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.04% | 2.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.04% | 2.38% | |||
| Cost of Revenue | 3.51% | 7.15% | |||
| Gross Profit | -4.63% | 0.30% | |||
| SG&A Expenses | -11.48% | 14.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.48% | 11.52% | |||
| Operating Income | 12.03% | -18.76% | |||
| Income Before Tax | 20.62% | -33.72% | |||
| Income Tax Expenses | 603.33% | -106.41% | |||
| Earnings from Continuing Operations | 2.33% | -0.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.33% | -0.70% | |||
| EBIT | 12.03% | -18.76% | |||
| EBITDA | 8.88% | -12.47% | |||
| EPS Basic | 3.61% | -1.95% | |||
| Normalized Basic EPS | 7.59% | -18.09% | |||
| EPS Diluted | 2.02% | -1.06% | |||
| Normalized Diluted EPS | 5.99% | -17.40% | |||
| Average Basic Shares Outstanding | -1.24% | 1.27% | |||
| Average Diluted Shares Outstanding | 0.25% | 0.43% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.02% | 0.01% | |||